Clinical Trial Update: Sutent Following Chemotherapy, Radiation and Surgery For Resectable Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of Sutent (sunitinib) following chemotherapy, radiation, and surgery for resectable esophageal cancer has completed. The document provides a trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Sutent (sunitinib)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Esophageal Cancer | Phase 2 | Status: COMPLETED